Ardent Health Inc. (ARDT) P/E Ratio History
Fairly ValuedTrading at 10.8x, near 5Y avg of 12.6x · 63th percentile · In line with own history · Data 2024–2026
Loading P/E history...
P/E Ratio Analysis
As of October 3, 2026, Ardent Health Inc. (ARDT) trades at a price-to-earnings ratio of 10.8x, with a stock price of $10.34 and trailing twelve-month earnings per share of $0.55.
The current P/E is 15% below its 5-year average of 12.6x. Over the past five years, ARDT's P/E has ranged from a low of 7.3x to a high of 29.4x, placing the current valuation at the 63th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.2x, ARDT trades at a 53% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.0x.
Relative to the broader market, ARDT trades at a notable discount to the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARDT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ARDT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ARDT P/E vs Peers
Hospitals and inpatient facilities peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $92B | 15.0 | 0.72 | +29% | |
| $22B | 16.7 | 0.51 | -53% | |
| $384M | 0.7Lowest | - | +197%Best | |
| $11B | 7.6 | 0.47Best | +37% | |
| $10B | 29.4 | 2.13 | +14% | |
| $2B | 14.0 | - | -29% | |
| $1B | 59.0 | - | -23% | |
| $108B | 23.5 | - | +49% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ARDT Historical P/E Data (2024–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $9.84 | $0.55 | 17.9x | +42% |
| FY2026 Q1 | - | $8.56 | $0.95 | 9.0x | -29% |
| FY2025 Q4 | Dec 31 2025 | $8.83 | $0.96 | 9.2x | -27% |
| FY2025 Q3 | - | $13.25 | $1.50 | 8.8x | -30% |
| FY2025 Q2 | Jun 30 2025 | $13.66 | $1.86 | 7.3x | -42% |
| FY2025 Q1 | Mar 31 2025 | $13.75 | $1.64 | 8.4x | -34% |
| FY2024 Q4 | - | $17.08 | $1.54 | 11.1x | -12% |
| FY2024 Q3 | Sep 30 2024 | $18.38 | $0.63 | 29.4x | +132% |
Average P/E for displayed period: 12.6x
ARDT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ARDT — Frequently Asked Questions
Quick answers to the most common questions about buying ARDT stock.
What is ARDT's P/E ratio?
Ardent Health Inc. (ARDT) trailing twelve-month P/E ratio is 10.8x, based on TTM diluted EPS of $0.55. The 5-year average P/E is 12.6x and the historical range spans 7.3x to 29.4x.
Is ARDT stock overvalued or undervalued?
ARDT trades at 10.8x P/E, near its 5-year average of 12.6x. The 63th percentile ranking within the 7.3x–29.4x historical range places valuation within normal bounds.
Is ARDT stock expensive?
ARDT is fairly valued relative to its own history. The current P/E of 10.8x is near the 5-year average of 12.6x (63th percentile of historical range).
What is ARDT's historical P/E range?
Over the past 5 years, ARDT's P/E ratio has ranged from 7.3x to 29.4x, with a median of 9.2x and an average of 12.6x. The current P/E of 10.8x places the stock at the 63th percentile of this range. Full historical data spans 2024–2026.
How does ARDT's P/E compare to the S&P 500?
ARDT trades at 10.8x P/E versus the S&P 500 median of 24.5x. The 56% discount to the market suggests lower growth expectations or perceived higher risk.
How does ARDT's valuation compare to Healthcare peers?
Ardent Health Inc. P/E of 10.8x compares to the Healthcare sector median of 23.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ARDT's PEG ratio?
ARDT PEG ratio is N/A, based on a P/E of 10.8x and EPS growth of -39.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ARDT's earnings yield?
ARDT earnings yield is 9.28%, the inverse of its 10.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.